- $0 consultation, treatment prices down 50%+*
- Canadian-licensed practitioners, fully online
- Free home delivery and ongoing care
Generic Semaglutide in Canada
In April 2026, Canada became the first G7 country to approve generic semaglutide. Health Canada has now approved generics from Dr. Reddy's and Apotex, plus Svemia, the first generic for chronic weight management. Compare licensed Canadian providers.
- Health Canada-approved generics: Dr. Reddy's, Apotex and Svemia
- Same active molecule as Ozempic and Wegovy, bioequivalent
- 45-90% cheaper than brand-name Ozempic
- Fully online, licensed Canadian physicians
- Generic semaglutide from $149/month
- $99 consult, then $60/month program fee
- Free 1-2 day delivery, all 10 provinces

- Free assessment, pay only if approved
- $149 month one, then $199/month all-in
- No consult or membership fees

- 100% online visit, no insurance needed
- Brand-name GLP-1 injections and oral options
- Free shipping in 1-2 business days
We may receive compensation when you click partner links. Rankings are based on our research methodology, not sponsorship.
How to choose Generic Semaglutide Canada providers
Look for providers that explicitly offer Health Canada-approved generic semaglutide (such as Svemia or Apotex or Dr. Reddy's semaglutide), have licensed Canadian physicians, transparent pricing, and can serve your province.
How it works
Complete an online health assessment, receive a review from a licensed Canadian physician, and if eligible receive a prescription for Health Canada-approved semaglutide shipped to your home.
Why people use these services
- Up to 90% savings vs. brand-name Ozempic
- Same active ingredient, bioequivalent to Ozempic
- Convenient online consultations with licensed Canadian physicians
- Medications shipped directly to your door across Canada
Generic Semaglutide Canada FAQ
What is generic semaglutide in Canada?
Generic semaglutide refers to Health Canada-approved generic versions of injectable semaglutide, the active molecule in Ozempic and Wegovy. In April 2026, Canada became the first G7 country to approve one. So far Health Canada has approved Dr. Reddy's generic semaglutide (Ozempic equivalent, April 28, 2026), Apotex generic semaglutide (Ozempic equivalent, May 1, 2026) and Svemia by Apotex (Wegovy equivalent, June 29, 2026). Health Canada is still reviewing more submissions, including from Sandoz, Teva, Taro and Aspen. Plosbrio and Poviztra are not generics: they are Novo Nordisk's own lower-priced renamed versions of Ozempic and Wegovy.
Is generic semaglutide the same as Ozempic?
The Ozempic-equivalent generics contain the same active molecule (semaglutide) as Ozempic. Health Canada requires bioequivalence, meaning the generic delivers the same amount of drug into the bloodstream at the same rate as the reference product. The pen device and excipients may differ slightly between manufacturers. Svemia is the equivalent of Wegovy, the weight management version of semaglutide.
How much cheaper is generic semaglutide vs. Ozempic in Canada?
Health Canada estimates generic semaglutide will be 45-90% cheaper than brand-name Ozempic. At launch, prices may be closer to 25-40% below brand. As more generics enter the market and production scales over 12-24 months, prices are expected to fall further.
Who can get generic semaglutide in Canada?
Dr. Reddy's and Apotex generic semaglutide (Ozempic equivalents) are approved for adults with type 2 diabetes. Svemia by Apotex (Wegovy equivalent) is approved for chronic weight management in patients aged 12 and older. A licensed Canadian physician must conduct a clinical assessment before prescribing. Eligibility for weight management typically requires a BMI of 30 or higher, or 27 or higher with a weight-related health condition.
Are Plosbrio and Poviztra generic semaglutide?
No. Plosbrio and Poviztra are Novo Nordisk's own renamed, lower-priced versions of Ozempic and Wegovy, approved by Health Canada in December 2025. They are not generics and are not made by Dr. Reddy's or Apotex.
Are compounded weight loss injections available in Canada?
No. Unlike the United States, Health Canada does not permit compounded versions of GLP-1 weight loss injections such as compounded semaglutide or tirzepatide. Canadian providers offer only Health Canada-approved products: brand-name medications (Ozempic, Wegovy, Saxenda), Novo Nordisk's renamed Plosbrio and Poviztra, or the approved generics (Dr. Reddy's, Apotex and Svemia).
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →Some links are affiliate links and may generate commission at no extra cost to you. Medical content is informational only and does not replace professional diagnosis or treatment. Generic semaglutide (Plosbrio, Poviztra) is approved by Health Canada for type 2 diabetes. Off-label prescribing for weight management is at physician discretion. Advertising disclosure.